Literature DB >> 27082152

The influence of miR-34a expression on stemness and cytotoxic susceptibility of breast cancer stem cells.

Hongyao Zhang1, Ning Li1, Jiahui Zhang1, Fengjiao Jin1, Meihua Shan1, Junfang Qin1, Yue Wang1.   

Abstract

In this study, we investigate the effect of miR-34a expression and biological characteristics of breast cancer stem cells (BCSCs). The mammospheres were formed from murine breast cancer cell line 4T1 and regarded as murine BCSCs. Identification of stemness molecules and cloning experiments validate the biological characteristics of BCSCs we have established. We showed that miR-34a, as a tumor suppressor, could separately reduce the stemness of BCSCs and activate the cytotoxic susceptibility of BCSCs to natural killer (NK) cells in vitro via down regulating the expression of Notch1 signaling molecules. Moreover, miR-34a could completely restrain established mice breast tumor xenografts in vivo in the NOD/SCID mice that have functional NK cells at a normal level, whereas it was less effective in NOD/SCID/ CD122/IL-2Rβ mice that do not have functional NK cells. We conclude that miR-34a is a crucial, dual tumor suppressor and BCSCs-targeting immunotherapeutic agent and has shown efficacy in the treatment of murine breast cancer. The results also suggest that impaired NK cells could contribute to the resistance to therapies.

Entities:  

Keywords:  Cytotoxic susceptibility; Notch1; ligand; miR-34a

Mesh:

Substances:

Year:  2016        PMID: 27082152      PMCID: PMC4990398          DOI: 10.1080/15384047.2016.1177678

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  37 in total

1.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

2.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

Review 3.  On the stem cell origin of cancer.

Authors:  Stewart Sell
Journal:  Am J Pathol       Date:  2010-04-29       Impact factor: 4.307

4.  Frequent downregulation of miR-34 family in human ovarian cancers.

Authors:  David C Corney; Chang-Il Hwang; Andres Matoso; Markus Vogt; Andrea Flesken-Nikitin; Andrew K Godwin; Aparna A Kamat; Anil K Sood; Lora H Ellenson; Heiko Hermeking; Alexander Yu Nikitin
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

5.  Effects of Notch-1 down-regulation on malignant behaviors of breast cancer stem cells.

Authors:  Gong-Ling Peng; Ye Tian; Chong Lu; Hui Guo; Xiang-Wang Zhao; Ya-Wen Guo; Long-Qiang Wang; Qiu-Li Du; Chun-Ping Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-04-08

6.  RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.

Authors:  Manuel A Friese; Jörg Wischhusen; Wolfgang Wick; Markus Weiler; Günter Eisele; Alexander Steinle; Michael Weller
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

7.  A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells.

Authors:  Pengcheng Bu; Kai-Yuan Chen; Joyce Huan Chen; Lihua Wang; Jewell Walters; Yong Jun Shin; Julian P Goerger; Jian Sun; Mavee Witherspoon; Nikolai Rakhilin; Jiahe Li; Herman Yang; Jeff Milsom; Sang Lee; Warren Zipfel; Moonsoo M Jin; Zeynep H Gümüş; Steven M Lipkin; Xiling Shen
Journal:  Cell Stem Cell       Date:  2013-05-02       Impact factor: 24.633

8.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

9.  Evidence of Notch-Hesr-Nrf2 Axis in Muscle Stem Cells, but Absence of Nrf2 Has No Effect on Their Quiescent and Undifferentiated State.

Authors:  Masahiko Yamaguchi; Satoshi Murakami; Tomohiro Yoneda; Miki Nakamura; Lidan Zhang; Akiyoshi Uezumi; Sumiaki Fukuda; Hiroki Kokubo; Kazutake Tsujikawa; So-Ichiro Fukada
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

10.  Acute Lymphoblastic Leukemia Cells Inhibit the Differentiation of Bone Mesenchymal Stem Cells into Osteoblasts In Vitro by Activating Notch Signaling.

Authors:  Gui-Cun Yang; You-Hua Xu; Hong-Xia Chen; Xiao-Jing Wang
Journal:  Stem Cells Int       Date:  2015-08-03       Impact factor: 5.443

View more
  5 in total

Review 1.  MicroRNAs, a Promising Target for Breast Cancer Stem Cells.

Authors:  Plabon Kumar Das; Mst Ayesha Siddika; Saharia Yeasmin Asha; Suraiya Aktar; Md Abdur Rakib; Jahan Ara Khanam; Suja Pillai; Farhadul Islam
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

2.  LncRNA SNHG7 Mediates the Chemoresistance and Stemness of Breast Cancer by Sponging miR-34a.

Authors:  Zhi-Hua Li; Ni-Si Yu; Qing Deng; Yulu Zhang; Yang-Yang Hu; Gang Liu; Kedi Huang
Journal:  Front Oncol       Date:  2020-11-24       Impact factor: 6.244

3.  Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models.

Authors:  Miao Miao; Henry Masengere; Guang Yu; Fengping Shan
Journal:  Biomed Res Int       Date:  2021-11-10       Impact factor: 3.411

Review 4.  Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.

Authors:  Wenmin Chen; Lu Zhang; Suling Liu; Ceshi Chen
Journal:  Cells       Date:  2022-09-20       Impact factor: 7.666

5.  Regorafenib suppresses colon tumorigenesis and the generation of drug resistant cancer stem-like cells via modulation of miR-34a associated signaling.

Authors:  Mao-Hua Cai; Xiao-Gang Xu; Shi-Li Yan; Ze Sun; Yin Ying; Bai-Kui Wang; Yue-Xing Tu
Journal:  J Exp Clin Cancer Res       Date:  2018-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.